InvestorsObserver
×
News Home

Should You Hold Tempest Therapeutics Inc (TPST) Stock Friday Morning?

Friday, March 01, 2024 08:19 AM | InvestorsObserver Analysts

Mentioned in this article

Should You Hold Tempest Therapeutics Inc (TPST) Stock Friday Morning?

Tempest Therapeutics Inc (TPST) has gained Friday morning, with the stock climbing 2.43% in pre-market trading to 3.8. TPST's short-term technical score of 65 indicates that the stock has traded more bullishly over the last month than 65% of stocks on the market. In the Biotechnology industry, which ranks 91 out of 146 industries, Tempest Therapeutics Inc ranks higher than 76% of stocks. Tempest Therapeutics Inc has risen 0.27% over the past month, closing at $4.04 on February 2. During this period of time, the stock fell as low as $3.65 and as high as $4.47. TPST has an average analyst recommendation of Strong Buy. The company has an average price target of $20.00.

Overall Score - 61
TPST has an Overall Score of 61. Find out what this means to you and get the rest of the rankings on TPST!
Tempest Therapeutics Inc has a Long-Term Technical rank of 37. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 63% of the market scoring higher. In the Biotechnology industry which is number 51 by this metric, TPST ranks better than 51% of stocks.

Important Dates for Investors in TPST:

-Tempest Therapeutics Inc is set to release earnings on 2024-03-27. Over the last 12 months, the company has reported EPS of $-2.20. -We do not have a set dividend date for Tempest Therapeutics Inc at this time. Click Here To Get The Full Report on Tempest Therapeutics Inc (TPST)

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App